Skip to main content

Event: Industrial biotechnology versus COVID-19

Thursday 7th July 2022, 9:30 to 11:45 am (UK time)

This online event will showcase contributions of industrial biotechnology (IB) to tackling the SARS-Cov-2 pandemic. A target audience is BBSRC DTP/CTP students and early career researchers who may be inspired to consider a career in IB. The event is jointly run with the bioprocessing network BioProNET2.

Welcome and Introductory remarks
Contributions of IB to the COVID-19 response, BioProNET2 and the BBSRC NIBB
9:30 Professor Mark Smales, BBSRC Biopharmaceutical Steering Group and University of Kent
9:35 Professor Nigel Robinson, E3B BBSRC NIBB Director and Durham University

Development of the Oxford vaccine
9:40 Introduction from Professor Dame Sarah Gilbert, University of Oxford
9:45 Professor Catherine Green, University of Oxford

Manufacture of the Oxford AstraZeneca vaccine
10:05 Dr Carol Knevelman, Oxford Biomedica

Development of monoclonal antibodies (mAbs) for SARS-Cov-2
10:25 Dr Chris Sellick, Sanofi

10:45 Break

Development and manufacture of SARS-Cov-2 lateral flow tests
10:55 Professor Paul Davis, Mologic Ltd

Next-generation mRNA vaccines
11:15 Professor Cleo Kontoravdi, Imperial College London

Summary and close
11:35 Professor Nigel Robinson/Professor Mark Smales
11:45 Close

To register, please book via the link here and join the network via a simple (2 min) form if you are not already a member. To contact us e-mail: [email protected].